The role of hippocampus in the pathophysiology of bipolar disorder

Behavioural Pharmacology

Volumn 18, Issue 5-6, 2007, Pages 419-430

  Frey, Benicio N ^a,e   Andreazza, Ana C ^a,b   Nery, Fabiano G ^c,f,g   Martins, Marcio R ^d   Quevedo, João ^d   Soares, Jair C ^h   Kapczinski, Flávio ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^e MCGILL UNIVERSITY   (Canada)

^f Mays Cancer Center at UT Health San Antonio   (United States)

^g SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Bipolar disorder; Brain imaging; Hippocampus; Mood stabilizers; Pathophysiology; Postmortem

Indexed keywords

AMPA RECEPTOR; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BAG 1 PROTEIN; CALCIUM BINDING PROTEIN; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; PROTEIN BCL 2; QUETIAPINE; VALPROIC ACID;

BIPOLAR DISORDER; BRAIN BLOOD FLOW; BRAIN REGION; COGNITION; DECLARATIVE MEMORY; DRUG EFFICACY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HUMAN; MONOTHERAPY; NERVE CELL PLASTICITY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEURONAL PLASTICITY;

EID: 34548383980     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282df3cde     Document Type: Review

References (143)

1. Adler CM, Levine AD, DelBello MP, Strakowski SM (2005). Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry 58:151-157.
2. Adler CM, DelBello MP, Jarvis K, Levine A, Adams J, Strakowski SM (2007). Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry 61:776-781.
3. Altshuler LL, Bartzokis G, Grieder T, Curran J, Jimenez T, Leight K, et al. (2000). An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry 48:147-162.
4. Altshuler LL, Bookheimer SY, Townsend J, Proenza MA, Eisenberger N, Sabb F, et al. (2005). Blunted activation in orbitofrontal cortex during mania: a functional magnetic resonance imaging study. Biol Psychiatry 58: 763-769.
5. Araujo F, Ruano D, Vitorica J (1999). Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties. J Pharmacol Exp Ther 290:989-997.
6. Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, Tezcan E, Ogur E (2006). Hippocampal 1H MRS in first-episode bipolar I patients. Prog Neuropsychopharmacol Biol Psychiatry 30:1235-1239.
7. Atmaca M, Yildirim H, Ozdemir H, Ogur E, Tezcan E (2007). Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychol Med 37:121-129.
8. Bearden CE, Hoffman KM, Cannon TD (2001). The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review.Bipolar Disord 3:106-150.
9. Bearden CE, Thompson PM, Dutton RA, Frey BN, Peluso MAM, Nicoletti M, et al. (2007). Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology (in press).
10. Bearden CE, Glahn DC, Monkul ES, Barrett J, Najt P, Kaur S, et al. (2006a). Sources of declarative memory impairment in bipolar disorder: Mnemonic processes and clinical features. J Psychiatr Res 40:47-58.
11. Bearden CE, Glahn DC, Monkul ES, Barrett J, Najt P, Villareal V, et al. (2006b). Patterns of memory impairment in bipolar disorder and unipolar major depression. Psychiatry Res 142:139-150.
12. Beckmann H, Jakob H (1991). Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? J Neural Transm Gen Sect 84:155-164.
13. Belmaker RH (2004). Bipolar disorder. N Engl J Med 351:476-486.
14. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44:88-97.
15. Benes FM, Berretta S. (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27.
16. Benes FM, Matzilevich D, Burke RE, Walsh J (2006). The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry 11:241-251.
17. Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH (2007). Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology, (in press).
18. Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, et al. (2003). Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 53:906-913.
19. Beyer JL, Kuchibhatla M, Payne ME, Moo-Young M, Cassidy F, MacFall J, et al. (2004). Hippocampal volume measurement in older adults with bipolar disorder. Am J Geriatr Psychiatry 12:613-620.
20. Blumberg HP, Kaufman J, Martin A, Whiteman R, Zhang JH, Gore JC, et al. (2003). Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry 60:1201-1208.
21. Bowley MP, Drevets WC, Ongur D, Price JL (2002). Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 52:404-412.
22. Bown CD, Wang JF, Young LT (2003). Attenuation of N-methyl-D-aspartate- mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers. Neuroscience 117:949-955.
23. Brambilla P, Harenski K, Nicoletti M, Sassi RB, Mallinger AG, Frank E, et al. (2003). MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res 37:287-295.
24. Brauch RA, Adnan El-Masri M, Parker JC Jr, El-Mallakh RS (2006). Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals. J Affect Disord 91:87-90.
25. Burgess N, Maguire EA, O'Keefe J (2002). The human hippocampus and spatial and episodic memory. Neuron 35:625-641.
26. Buzsaki G (1997). Functions for interneuronal nets in the hippocampus. Can J Physiol Pharmacol 75:508-515.
27. Campbell S, Marriott M, Nahmias C, Macqueen GM (2004). Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 161:598-607.
28. Castren E (2005). Is mood chemistry? Nat Rev Neurosci 6:241-246.
29. Chang A, Li PP, Warsh JJ (2003). cAMP-Dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD). Brain Res Mol Brain Res 116:27-37.
30. Chen CH, Lennox B, Jacob R, Calder A, Lupson V, Bisbrown-Chippendale R, et al. (2006). Explicit and implicit facial affect recognition in manic and depressed states of bipolar disorder: a functional magnetic resonance imaging study. Biol Psychiatry 59:31-39.
31. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK (2000). Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75:1729-1734.
32. Coyle JT, Duman RS (2003). Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157-160.
33. Cui J, Shao L, Young LT, Wang JF (2007). Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144:1447-1453.
34. Damadzic R, Shuangshoti S, Giblen G, Herman MM (2002). Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression. Acta Neuropathol (Berl) 103:488-494.
35. Dean B, Scarr E, McLeod M (2005). Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder. Brain Res Mol Brain Res 138:145-155.
36. Deckersbach T, Savage CR, Reilly-Harrington N, Clark L, Sachs G, Rauch SL (2004). Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: the role of memory strategies. Bipolar Disord 6:233-244.
37. Deckersbach T, Dougherty DD, Savage C, McMurrich S, Fischman AJ, Nierenberg A, et al. (2006). Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder. Biol Psychiatry 59:138-146.
38. Deicken RF, Pegues MP, Anzalone S, Feiwell R, Soher B (2003). Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 160:873-882.
39. De Quervain DJ, Henke K, Aerni A, Treyer V, McGaugh JL, Berthold T, et al. (2003). Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur J Neurosci 17:1296-1302.
40. Dhikav V, Anand KS (2007). Is hippocampal atrophy a future drug target? Med Hypotheses 68:1300-1306.
41. Dickenstein DP, Milham MP, Nugent AC, Drevets WC, Charney DS, Pine DS, et al. (2005). Frontotemporal alterations in pediatric bipolar disorder. Arch Gen Psychiatry 62:734-741.
42. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT (1999). G Protein-coupled cyclic AMP signaling in postmortem brain of patients with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 73:1121-1126.
43. D'Sa C, Duman RS (2002). Antidepressants and neuroplasticity. Bipolar Disord 4:183-194.
44. Du J, Suzuki K, Wei Y, Wang Y, Blumenthal R, Chen Z, et al. (2007). The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 32:793-802.
45. Dunn RT, Kimbrell TA, Ketter TA, Frye MA, Willis MW, Luckenbaugh DA, Post RM (2002). Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry 51:387-399.
46. Eastwood SL, Harrison PJ (2000). Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 5:425-432.
47. Eichenbaum H (2000). A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 1:41-50.
48. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, et al. (2003). The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23:7311-7316.
49. Evan G, Littlewood T (1998). A matter of life and cell death. Science 281: 1317-1322.
50. Fatemi SH, Earle JA, McMenomy T (2000). Reduction in reelin immunoreactivity in hippocampus of patients with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 5:654-663.
51. Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J (2001). Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of patients with mood disorders and schizophrenia. NeuroReport 12:3257-3262.
52. Fields A, Li PP, Kish SJ, Warsh JJ (1999). Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J Neurochem 73:1704-1710.
53. Frank LM, Brown EN, Stanley GB (2006). Hippocampal and cortical place cell plasticity: implications for episodic memory. Hippocampus 16:775-784.
54. Frazier JA, Chiu S, Breeze JL, Makris N, Lange N, Kennedy DN, et al. (2005). Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry 162:1256-1265.
55. Freund TF, Buzsaki G (1996). Interneurons of the hippocampus. Hippocampus 6:347-470.
56. Frey BN, Andreazza AC, Cereser KM, Martins MR, Valvassori SS, Reus GZ, et al. (2006a). Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79:281-286.
57. Frey BN, Andreazza AC, Rosa AR, Martins MR, Valvassori SS, Reus GZ, et al. (2006b). Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol 17:311-318.
58. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, et al. (2006c). Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31: 326-332.
59. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001). Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158:100-106.
60. Glahn DC, Bearden CE, Caetano S, Fonseca M, Najt P, Hunter K, et al. (2005). Declarative memory impairment in pediatric bipolar disorder. Bipolar Disord 7:546-554.
61. Halliwell B (2006). Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634-1658.
62. Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, et al. (2004). Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci 24:6590-6599.
63. Harrison PJ (2002). The neuropathology of primary mood disorder. Brain 125:1428-1449.
64. Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang DM (2002). Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology 43:1173-1179.
65. Hauser P, Matochik J, Altshuler LL, Denicoff KD, Conrad A, Li X, et al. (2000). MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. J Affect Disord 60:25-32.
66. Heckers S, Konradi C (2002). Hippocampal neurons in schizophrenia. J Neural Transm 109:891-905.
67. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM (2002). Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 59:521-529.
68. Ito H, Kawashima R, Awata S, Ono S, Sato K, Goto R, et al. (1996). Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med 37:410-414.
69. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59:530-537.
70. Kim JS, Chang MY, Yu IT, Kim JH, Lee SH, Lee YS, Son H (2004). Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J Neurochem 89:324-336.
71. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF; Stanley Neuropathology Consortium (2004). Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9:609-620.
72. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S (2004). Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300-308.
73. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al. (2002). Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7 (Suppl 1):S71-S80.
74. Kupfer DJ (2005). The increasing medical burden in bipolar disorder. JAMA 293:2528-2530.
75. LaBar KS, Cabeza R (2006). Cognitive neuroscience of emotional memory. Nat Rev Neurosci 7:54-64.
76. Laezza F, Doherty JJ, Dingledine R (1999). Long-term depression in hippocampal interneurons: joint requirement for pre- and postsynaptic events. Science 285:1411-1414.
77. Lavenex P, Amaral DG (2000). Hippocampal-neocortical interaction: a hierarchy of associativity. Hippocampus 10:420-430.
78. Law AJ, Weickert CS, Hyde TM, Kleinman JE, Harrison PJ (2004). Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am J Psychiatry 161:1848- 1855.
79. Lawrence NS, Williams AM, Surguladze S, Giampietro V, Brammer MJ, Andrew C, et al. (2004). Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 55:578-587.
80. Lennox BR, Jacob R, Calder AJ, Lupson V, Bullmore ET (2004). Behavioural and neurocognitive responses to sad facial affect are attenuated in patients with mania. Psychol Med 34:795-802.
81. Liu L, Schulz SC, Lee S, Reutiman TJ, Fatemi SH. (2007). Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell Mol Neurobiol 27:351-358.
82. Lockhead RA, Parsey RV, Oquendo MA, Mann JJ (2004). Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry. Biol Psychiatry 55:1154-1162.
83. Lopez AD, Murray CC (1998). The global burden of disease, 1990-2020. Nat Med 4:1241-1243.
84. Maccaferri G, McBain CJ (1996). Long-term potentiation in distinct subtypes of hippocampal nonpyramidal neurons. J Neurosci 16:5334-5343.
85. MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C (2006). Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord 8:255-264.
86. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110.
87. Malhi GS, Lagopoulos J, Ward PB, Kumari V, Mitchell PB, Parker GB, et al. (2004). Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci 19:741-754.
88. Malhi GS, Lagopoulos J, Sachdev PS, Ivanovski B, Shnier R (2005). An emotional Stroop functional MRI study of euthymic bipolar disorder. Bipolar Disord 7(Suppl 5):58-69.
89. Manji HK, Duman RS (2001). Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 35:5-49.
90. Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J, et al. (2004). Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 161:262-270.
91. Marty S, Berninger B, Carroll P, Thoenen H (1996). GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor. Neuron 16:565-570.
92. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, et al. (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156:675-682.
93. McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH (2007). Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 1127:108-118.
94. McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B, et al. (2006). Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 163:478-487.
95. McEwen BS (1999). Stress and hippocampal plasticity. Annu Rev Neurosci 22:105-122.
96. McEwen BS, Magarinos AM (2001). Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol 16 (Suppl 1):S7-S19.
97. Mega MS, Cummings JL, Salloway S, Malloy P (1997). The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci 9:315-330.
98. Migliorelli R, Starkstein SE, Teson A, de Quiros G, Vazquez S, Leiguarda R, Robinson RG (1993). SPECT findings in patients with primary mania. J Neuropsychiatry Clin Neurosci 5:379-383.
99. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES (1999). Emotional bias and inhibitory control processes in mania and depression. Psychol Med 29:1307-1321.
100. Neumeister A, Charney DS, Drevets WC (2005). Hippocampus, VI. Depression and the hippocampus. Am J Psychiatry 162:1057.
101. Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16:2365-2372.
102. Noga JT, Vladar K, Torrey EF (2001). A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res 106:25-34.
103. Nonaka S, Hough CJ, Chuang DM (1998). Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A 95:2642-2647.
104. Ongur D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95:13290-13295.
105. Paradiso S, Lamberty GJ, Garvey MJ, Robinson RG (1997). Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis 185:748-754.
106. Pavuluri MN, Schenkel LS, Aryal S, Harral EM, Hill SK, Herbener ES, Sweeney JA (2006). Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients. Am J Psychiatry 163:286-293.
107. Pearlson GD, Barta PE, Powers RE, Menon RR, Richards SS, Aylward EH, et al. (1997). Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry 41:1-14.
108. Phillips ML, Drevets WC, Rauch SL, Lane R (2003a). Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry 54:504-514.
109. Phillips ML, Drevets WC, Rauch SL, Lane R (2003b). Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 54:515-528.
110. Rahman S, Li PP, Young LT, Kofman O, Kish SJ, Warsh JJ (1997). Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J Neurochem 68:297-304.
111. Rajkowska G (2003). Depression: what we can learn from postmortem studies. Neuroscientist 9:273-284.
112. Rajkowska G, Halaris A, Selemon LD (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 49:741-752.
113. Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, Latov N, et al. (2000). Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 57:349-356.
114. Rubinow DR, Post RM (1992). Impaired recognition of affect in facial expression in depressed patients. Biol Psychiatry 31:947-953.
115. Rubinsztein JS, Michael A, Paykel ES, Sahakian BJ (2000). Cognitive impairment in remission in bipolar affective disorder. Psychol Med 30:1025-1036.
116. Sala M, Perez J, Soloff P, Ucelli di Nemi S, Caverzasi E, Soares JC, Brambilla P (2004). Stress and hippocampal abnormalities in psychiatric disorders. Eur Neuropsychopharmacol 14:393-405.
117. Sapolsky RM (1996). Why stress is bad for your brain. Science 273:749-750.
118. Scarr E, Pavey G, Sundram S, MacKinnon A, Dean B (2003). Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord 5:257-264.
119. Shao L, Young LT, Wang JF (2005). Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 58:879-884.
120. Soares JC, Mann JJ (1997). The functional neuroanatomy of mood disorders. J Psychiatr Res 31:393-432.
121. Son H, Yu IT, Hwang SJ, Kim JS, Lee SH, Lee YS, Kaang BK (2003). Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus. J Neurochem 85:872-881.
122. Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM, et al. (1999). Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 56:254-260.
123. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, et al. (2002). Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 159:1841-1847.
124. Strakowski SM, Adler CM, Holland SK, Mills N, DelBello MP (2004). A preliminary fMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology 29:1734-1740.
125. Strakowski SM, Delbello MP, Adler CM (2005a). The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 10:105-116.
126. Strakowski SM, Adler CM, Holland SK, Mills NP, DelBello MP, Eliassen JC (2005b). Abnormal fMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task. Am J Psychiatry 162:1697-1705.
127. Strasser HC, Lilyestrom J, Ashby ER, Honeycutt NA, Schretlen DJ, Pulver AE, et al. (2005). Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study. Biol Psychiatry 57:633-639.
128. Swayze VW, Andreasen NC, Alliger RJ, Yuh WTC, Ehrhardt JC (1992). Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 31:221-240.
129. Sweeney JA, Kmiec JA, Kupfer DJ (2000). Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry 48:674-684.
130. Tian SY, Wang JF, Bezchlibnyk YB, Young LT (2007). Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia. Neurosci Lett 411:123-127.
131. Toro C, Deakin JF (2005). NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 80:323-330.
132. Tremont G, Halpert S, Javorsky DJ, Stern RA (2000). Differential impact of executive dysfunction on verbal list learning and story recall. Clin Neuropsychol 14:295-302.
133. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67:269-275.
134. Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ (2002). Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 7:571-578.
135. Videbech P, Ravnkilde B (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161:1957-1966.
136. Wada A, Yokoo H, Yanagita T, Kobayashi H (2005). Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci 99:307-321.
137. Walz JC, Frey BN, Andreazza AC, Cereser KM, Cacilhas AA, Valvassori SS, et al. (2007). Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. J Psychiatr Res (in press).
138. Wang Y, Fujita I, Murayama Y (2000). Neuronal mechanisms of selectivity for object features revealed by blocking inhibition in inferotemporal cortex. Nat Neurosci 3:807-813.
139. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS (2004). Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci U S A 101:3973-3978.
140. Yau JL, Olsson T, Morris RG, Meaney MJ, Seckl JR (1995). Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience 66:571-581.
141. Yucel K, Taylor VH, McKinnon MC, Macdonald K, Alda M, Young LT, Macqueen GM (2007). Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology (in press).
142. Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD (2000). fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord 2:237-248.
143. Zhou R, Gray NA, Yuan P, Li X, Chen J, Chen G, et al. (2005). The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. J Neurosci 25:4493-4502.